Compare TLN & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TLN | MEDP |
|---|---|---|
| Founded | 2015 | 1992 |
| Country | United States | United States |
| Employees | 1880 | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.7B | 11.7B |
| IPO Year | N/A | 2016 |
| Metric | TLN | MEDP |
|---|---|---|
| Price | $349.46 | $411.12 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 12 | 12 |
| Target Price | $432.08 | ★ $473.17 |
| AVG Volume (30 Days) | ★ 596.8K | 442.5K |
| Earning Date | 05-05-2026 | 04-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 20.98 |
| EPS | N/A | ★ 4.28 |
| Revenue | N/A | N/A |
| Revenue This Year | $59.63 | $13.19 |
| Revenue Next Year | $16.08 | $7.75 |
| P/E Ratio | ★ $83.51 | $95.74 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $216.20 | $284.10 |
| 52 Week High | $451.28 | $628.92 |
| Indicator | TLN | MEDP |
|---|---|---|
| Relative Strength Index (RSI) | 53.10 | 34.96 |
| Support Level | $345.48 | $410.09 |
| Resistance Level | $397.04 | $485.13 |
| Average True Range (ATR) | 15.46 | 17.87 |
| MACD | 2.31 | -12.67 |
| Stochastic Oscillator | 65.87 | 25.06 |
Talen Energy Corp is an independent power producer and energy infrastructure company based in the United States. It owns and operates several gigawatts of power infrastructure in the United States, including 2.2GW of nuclear power and a dispatchable fossil fleet. The company produces and sells electricity, capacity, and ancillary services into wholesale U.S. power markets, with its generation fleet principally located in the Mid-Atlantic, Ohio, and Montana. Talen's operating segments are: PJM and Others. The PJM segment, which generates maximum revenue, is engaged in electricity generation, marketing activities, and commodity risk and fuel management within the PJM market and is comprised of Susquehanna and Talen's natural gas and coal generation facilities in PJM.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.